摘要
高迁移率族蛋白B1(high-mobility group box 1,HMGB1)是一种保守的核蛋白,对维持核小体稳定、DNA重组、复制、修复及转录有重要作用。其可由坏死的细胞被动释放,或在适宜刺激下主动分泌至胞外。近年的研究显示:HMGB1信号的活化与肺损伤、肺纤维化、肺癌等肺部疾病的发展密切相关,而阻断HMGB1信号可抑制其病理进程,说明HMGB1的抑制对这类疾病有潜在治疗价值。该文就HMGB1在呼吸系统疾病中的作用及其机制作一综述,以期为上述疾病的诊断和治疗提供新的理论依据。
High-mobility group box 1 ( HMGB1 ) is a conserva-tive nuclear protein and plays an essential role in maintaining nu-cleosome stability, DNA recombination, replication, repair and transcription. It can be passively released by necrotic cells or ac-tively secreted into extracellular under appropriate stimulus. Re-cent studies show that the activation of HMGB1 signaling is closely related to the progress of lung diseases including lung in-jury, pulmonary fibrosis and lung cancer, while blocking HMGB1 signaling inhibits the pathological process, indicating the therapeutic potential of HMGB1 inhibition in treating these diseases. This review summarizes the role and mechanisms of HMGB1 in such diseases, in order to provide novel evidence for the diagnosis and treatment.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2015年第1期15-18,共4页
Chinese Pharmacological Bulletin
基金
国家自然科学基金资助项目(No 81274172
81473267
30801535)
"天然药物活性组分与药效"国家重点实验室(中国药科大学)开放课题(No sklnmkf201206)
安徽省卫生厅中药研究项目(No 2012zy53)